Aims: To define the natural history of patients with suspicious urinary cytology and negative initial evaluation for malignancy in the investigation of haematuria. Patients and methods: Data from the hospital information support system on urinary cytology examinations carried out at one centre were audited over a period of 24 months. There were 102 patients who had suspicious urinary cytology for malignant cells with negative initial evaluation. Follow up investigations, treatment, and final outcome were noted. Results: There were 102 patients with suspicious urinary cytology and negative initial evaluation for malignancy in 24 months, with a mean follow up of 15.7 months. Seventy patients had no obvious pathology on initial investigations. Forty one patients were found to have urological malignancies (29 bladder, eight ureteric, and four prostate) on follow up. All patients diagnosed as having urothelial malignancies on follow up had either persistent suspicious cytology (29) or recurrent haematuria (eight). The mean duration for appearance of lesions was 5.6 months (range, 3-12 months). Three patients had suspicious digital rectal examination and biopsies confirmed adenocarcinoma of the prostate. One patient had urinary retention and transurethral resection of prostate showed prostatic adenocarcinoma. The presence of suspicious cells on repeat urine analysis was the only significant factor in predicting the presence of urothelial tumours (p = 0.002). Conclusion: Patients with persistent suspicious/positive cytology or recurrent haematuria need further evaluation and follow up. Asymptomatic patients or patients with obvious benign pathology do not require repeat evaluation. Careful urological evaluation, including prostate, should be carried out in these patients.
Aims: To define the natural history of patients with suspicious urinary cytology and negative initial evaluation for malignancy in the investigation of haematuria. Patients and methods: Data from the hospital information support system on urinary cytology examinations carried out at one centre were audited over a period of 24 months. There were 102 patients who had suspicious urinary cytology for malignant cells with negative initial evaluation. Follow up investigations, treatment, and final outcome were noted. Results: There were 102 patients with suspicious urinary cytology and negative initial evaluation for malignancy in 24 months, with a mean follow up of 15.7 months. Seventy patients had no obvious pathology on initial investigations. Forty one patients were found to have urological malignancies (29 bladder, eight ureteric, and four prostate) on follow up. All patients diagnosed as having urothelial malignancies on follow up had either persistent suspicious cytology (29) or recurrent haematuria (eight). The mean duration for appearance of lesions was 5.6 months (range, 3-12 months). Three patients had suspicious digital rectal examination and biopsies confirmed adenocarcinoma of the prostate. One patient had urinary retention and transurethral resection of prostate showed prostatic adenocarcinoma. The presence of suspicious cells on repeat urine analysis was the only significant factor in predicting the presence of urothelial tumours (p = 0.002). Conclusion: Patients with persistent suspicious/positive cytology or recurrent haematuria need further evaluation and follow up. Asymptomatic patients or patients with obvious benign pathology do not require repeat evaluation. Careful urological evaluation, including prostate, should be carried out in these patients.
T he widely used Papanicolaou and Marshal 1 classification of urinary cytological examination considers class I-II as negative and class IV-V as positive for the presence of malignant cells. The class III or suspicious group remains controversial. Suspicious urinary cytology in clinical practice necessitates thorough investigations to rule out the presence of urothelial malignancy. Most clinicians treat this as malignant, leading to repeated evaluations and follow up, which in most of these patients remain inconclusive. Lack of guidelines in the literature regarding the management of these patients, variations in urine specimen processing, subjective interpretation of cytological analysis, and lack of a standard method of reporting urinary cytology are some of the difficulties in decision making on this issue. Clearly, there remains a group of patients who are over investigated. We analysed our results in the present study to answer the question of how to follow up suspicious urinary cytology in a patient with a history of haematuria and normal initial investigations? We defined suspicious urinary cytology as (a) not clearly indicative of malignancy or (b) cannot clearly exclude the presence of malignancy. The aims of our study were:
(1) To define the natural history of patients with suspicious urine cytology and negative evaluation for malignancy. (2) To determine a subgroup of these patients with increased risk of developing malignancy. (3) To develop guidelines for the follow up of these patients.
PATIENTS AND METHODS
Data from the hospital information support system on urinary cytology examinations carried out at one centre were audited over a period of 24 months. Age, sex, history of persistent microscopic or gross haematuria, history of smoking, occupational exposure, follow up investigations, treatment, and final outcome were noted from the hospital records. A record of clinical profile and investigations generated by suspicious urinary cytology was made. Patients with obvious malignancy on initial investigations were excluded from our study. A group of patients who had suspicious urinary cytology (not clearly malignant or cannot exclude presence of malignancy) with negative initial evaluation was defined. The initial investigations usually comprised flexible cystoscopy, intravenous urogram, and abdomenal ultrasound, followed by rigid cystoscopy with bilateral ureteric washings and retrograde studies, wherever necessary. If washings or retrograde studies showed an abnormality, ureteroscopy (with or without biopsies) was carried out. Patients with negative initial investigations were followed up in clinic after six to eight weeks and repeat urinary cytology was requested. Persistence of suspicious urinary cytology or symptoms required repeat evaluation. Patients in whom repeat urinary cytology at six to eight weeks showed no evidence of malignant cells were followed at three monthly intervals, both clinically and with repeat voided urinary cytological analysis.
RESULTS
There were 102 patients with suspicious urinary cytology and negative initial evaluation for malignancy among those in whom cytological examinations were carried out over a period of 24 months. The mean follow up of our study was 15.7 months (range, 10-24). There were 76 male and 26 female patients. The mean age was 61.7 (range, 51-72) years. A history of smoking was present in 60 patients. Patients were divided into two groups (figs 1 and 2). Group 1 (32) consisted of patients with benign pathology on evaluation. Group 2 (70) consisted of patients with no obvious pathology on investigation (fig 2) . This last group was further subdivided into four subgroups. Subgroup A (37) consisted of patients who persisted with suspicious cytology or symptoms and developed malignancy diagnosed on further evaluation. The mean duration for appearance of a lesion was 5.6 months (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Subgroup B (four) consisted of patients in whom repeat prostate evaluation confirmed adenocarcinoma of the prostate. Subgroup C (25) comprised patients with persistent normal cytological analysis carried out at least six to eight weeks apart and who showed no evidence of malignancy on further evaluation. Subgroup D (four) comprised patients who had persistent suspicious urinary cytology with no evidence of malignancy on repeat investigation. Patients in subgroup A were subsequently found to have urological tumours (eight ureteric and 29 bladder; fig 3) . Urothelial malignancy was diagnosed in 29 of these patients on further investigation after initial negative evaluation as a result of persistent positive or suspicious cytology at the time of the second investigation. Eight patients had recurrent episodes of haematuria and reevaluation showed urothelial tumours. In subgroup B, three patients had suspicious digital rectal examination results, and biopsies confirmed adenocarcinoma of the prostate. All these patients had previous evaluation for suspected carcinoma of the prostate, including biopsies with no evidence of malignancy. One patient had urinary retention and transurethral resection of the prostate showed adenocarcinoma of the prostate. None of the patients with benign pathology (stones, longterm catheters, pelviureteric junction obstruction, previous instrumentation) or normal cytological analysis on repeat evaluation was found to have evidence of malignancy on follow up. The presence of suspicious cells on repeat urine analysis was the only significant factor in predicting the presence of urothelial tumours (p = 0.002). Age, sex, and history of smoking were not significant.
DISCUSSION
In 1864, Sanders first described the presence of exfoliated neoplastic cells in the urine. 2 In 1945, 1 its use in the diagnosis of urothelial malignancy was reported. Since that time, urine cytology has gained widespread acceptance as a useful investigation of individuals with haematuria. However, despite its extensive use in routine practice, urine cytology has several important drawbacks. Several large series have shown that urine cytology has a low sensitivity, varying between 42% and 66% depending on the population studied. Specificity rates are higher, but rarely exceed 97% in routine practice. [3] [4] [5] [6] [7] [8] Unlike other forms of cytological assessment, such as breast cytology, urine cytology does not target an abnormal area but relies on neoplastic cells being shed in the urine. It is well recognised that high grade urothelial tumours, including carcinoma in situ, are more likely to shed abnormal cells into the urine. These cells are more atypical, permitting easier and more confident recognition by the reporting cytologist. It is not surprising then that sensitivity rates are higher for tumours of higher grade. The corollary is that low grade tumours are less likely to shed cells into the urine. The cells that are shed vary little from normal urothelial cells, apart from a tendency to be shed in clusters rather than as single cells. Interpretation of these subtle changes is very difficult. Additional problems in urine cytology are that stones, infections, urinary tract instrumentation, and chemotherapy/radiotherapy can all cause changes in the urine cytology picture that mimic malignancy, leading to an erroneous diagnosis by the unwary. [9] [10] [11] Urine cytology specimens reported as being suspicious of malignancy require further clinical evaluation of the patient by the attending urologist. This can cause undue anxiety in the patient who is worried about the prospect of undiagnosed malignancy and who has to face a series of often uncomfortable and unpleasant investigations. The urologist may be faced with the situation where all other initial investigations are negative apart from urine cytology, and it is often unclear how to proceed with follow up in the absence of specific guidelines. Most studies that have evaluated the outcome of patients who have been reported as having atypical urine cytology show that less that 50% of these individuals are found to have malignancy. This suggests that only half of those with atypical urine cytology need careful follow up, and that currently a large number of patients are subjected to unnecessary investigations, with resultant wastage of valuable resources and time. The aim of our study was to try to assess whether there were specific criteria that could determine those patients who need to be subjected to careful follow up and those patients who could safely be discharged.
''The injudicious use of urine cytology in individuals who have an obvious cause of haematuria, such as urinary tract stones, is to be avoided because it may lead to suspicious results being generated'' Thirty one percent of our patients with an initial suspicious urinary cytology result and negative initial evaluation were found to have a benign disease that could explain their abnormal result. None of this group had abnormal cytology results on repeat follow up and all of the patients are now asymptomatic. This group highlights the problem of benign pathology causing significant atypia in voided urothelial cells. It also emphasises the need to provide accurate and complete clinical details to the pathology department when submitting the specimen. Urine cytology specimens are high volume specimens. Frequently, the request form arrives with no clinical details, which can lead to misinterpretation of the changes by the reporting cytopathologist. This problem is compounded by increasing workload pressures on pathology laboratories, which prevents follow up of each abnormal urine specimen. The injudicious use of urine cytology in individuals who have an obvious cause of haematuria, such as urinary tract stones, is to be avoided because it may lead to suspicious results being generated. This emphasises the need for urologists to have strict criteria governing which individuals should be subjected to urine cytology to avoid this happening.
Four patients in our study group had persistently atypical cells in their urine despite initial normal evaluation. All of these patients were found to have abnormal prostates on review examination, and were confirmed to have prostate adenocarcinoma on histology. In our present series, all patients showed high grade adenocarcinoma (Gleason score . 7) on histology. This is similar to that reported previously by Rupp et al. 12 Several reports have described the cytological features of malignant cells from prostatic carcinoma within voided urine samples. Krishnan and colleagues 13 described the cells as having oval nuclei with smooth borders, powdery evenly distributed nuclear chromatin, large prominent nucleoli, and lacking appreciable pleomorphism. However, the recognition of these subtle differences is difficult, and distinguishing these cells from atypical cells of urothelial type may be almost impossible except in rare circumstances. In male patients with persistently atypical cells in their urine, careful assessment of the prostate is recommended, particularly when there is no evidence of malignancy on initial evaluation. In selected cases, there may also be a role for immunohistochemical staining for prostate specific antigen on the urine sample to help identify the profile of the atypical cells. 14 15 Forty one (40%) of our patients had persistent haematuria or persistent atypical cells in their urine despite a negative evaluation for malignancy at the initial diagnostic investigation. Thirty seven of these patients were subsequently found to have a urothelial malignancy on repeat evaluation. Eight of these occurred in the ureter and 29 in the bladder. The mean duration for the appearance of these lesions was 5.6 months (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . The reasons why the bladder tumours were not readily apparent at initial assessment are unclear. It may be that the tumours were of small size, were in areas of the bladder not readily assessable with a flexible cystoscope, or that the operator was inexperienced or under time pressure because of a high throughput of patients. Our study shows that patients who have persistently abnormal urine cytology should be assessed very carefully, preferably with rigid cystoscopy, and by an experienced urologist before the bladder and upper tracts can be said to be normal.
There still remains a small group of four patients (3%) within our study who showed suspicious cytology despite careful follow up. As in other areas of cytology, there will always be a small false positive rate even in the most expert centres. However, it is probably worthwhile reviewing the specimens in this group and considering seeking an expert opinion. It is difficult to recommend how long these patients should be followed for. Because most of the tumours in our series presented in the first 12 months after an abnormal cytology result, it would seem appropriate to review them regularly for 12-18 months and then to consider discharging them back to primary care buddy, I don't trust you.
(6) Please issue duplicate slides for further management: I still don't trust you. (7) 2500 ml of urine from a dipsomaniac, to look for malignant cells: I didn't know how to discard it. (8) 0.5 6 0.5 cm axillary node for FNAC, patient is HIV positive: I don't have the nerve to biopsy it. (9) Please look for Helicobacter pylori: the consumer forum president has become flatulent; scopy's normal, tummy's no trouble; dig into that haystack, find a needle, and save us all from the ordeal. (10) Request for a complete necropsy on a patient who died 420 days after an aspirate from a lipomatous swelling on his right little toe: we don't know why he died, but we're hoping to pin the blame on you. ....................................................................................... Guidelines for authorship of biomedical journals have been available for nearly two decades now to help determine how attribution should be acknowledged. 1 With an increasing number of multiauthored articles and with contributions from diverse specialties, authorship disputes will always raise their head because existing guidelines may not be followed stringently or may be misinterpreted. I analysed author numbers in the Indian Journal of Pathology and Microbiology over the past 28 years . The designation of various authors or their individual contributions to the authored papers was not ascertained. In total, 1861 articles comprising 1268 (68.1%) original articles and 593 (31.9%) case reports were studied.
T Rajalakshmi
The number of authors for original articles ranged from one to a maximum of 10 (mean, 3.4). The mean number of authors for each article showed a significant increase from 1. The International Committee of Medical Journal Editors (Vancouver group) drew up the guidelines for authorship based on the principle that each author should be able to defend the work publicly. However, several studies have shown that these guidelines are not followed and the literature abounds with examples of irresponsible authorship.
2-4 Some researchers have recommended doing away with the present designation of author and replacing it with that of a contributor. 5 In India, with many researchers being unfamiliar with the Vancouver guidelines, authorship is, on many occasions, a political decision determined by the position of the author in the hierarchy ladder. Not many junior researchers have the courage to refuse polite implicit or explicit requests from their seniors for inclusion as co-authors, even if their contribution to the work was negligible. The complex factors in the authorship tangle can operate in the reverse direction also, with juniors including senior investigators as co-authors to increase the credibility of the paper and its chances of being accepted. The conferral of gift authorship also erodes the pillars of ethical attribution. All these practices violate the Vancouver guidelines and cause much anguish to those forced to include noncontributors as co-authors in their work or those who are denied authorship when it is deserved. Authors must accept responsibility for a publication when taking the credit for the same. Institutions also need to address authorship issues head on, and devise ways to deal with such disputes. This vital activity in the biomedical field should not be converted into a power game where only the mighty win. 1 Type B inclusions are basophilic and occur early in the viral replication cycle. They represent the actual site of viral replication in the cytoplasm and may be seen in all productive poxvirus infections. In contrast, type A inclusions are large, well defined, eosinophilic bodies that develop late in the viral replication cycle. They are composed entirely of a single protein species that has a molecular weight of 160 kDa, but their function is not understood. 2 Type A inclusions are only associated with certain poxvirus infections so that their detection may be diagnostically useful.
N Kakkar
We recently reported the clinical presentation of a veterinary surgeon working at a small animal practice who developed a black necrotic ulcer on his finger. 3 Histopathology of a punch biopsy of the lesion unexpectedly revealed epidermal hyperplasia, neutrophil infiltration, and the presence of numerous large eosinophilic intracytoplasmic inclusions, consistent with poxvirus infection (fig 1) . Based on this appearance, the differential diagnosis included cowpox (an orthopoxvirus infection), orf, and pseudocowpox (both parapoxvirus infections). In the context of frequent occupational exposure to cat scratches but no contact with ungulates, cowpox was the most probable diagnosis. This diagnosis was confirmed by polymerase chain reaction and partial DNA sequencing. Human cowpox is an uncommon and probably underdiagnosed infection that occurs only in Europe. 4 Despite the name, cowpox is rare in cattle. Human infections are probably most frequently acquired from infected cats shedding virus from skin lesions, which gain entry to the human skin through abrasions or scratches. 4 5 Laboratory diagnosis of cowpox may be established by electron microscopy of vesicle fluid, by polymerase chain reaction, virus isolation, or serology. However, in our case the histopathological appearances were important in establishing a probable diagnosis of human cowpox before molecular virological confirmation at a reference laboratory. Cowpox virus is recognised as causing large intracytoplasmic inclusion bodies in infected feline tissues and in in vitro cell culture. 4 However, such inclusions were not reported among the biopsied cases included in an extensive review of this disease, in which a total of 54 published and unpublished human cases were reviewed. 4 Indeed, an extensive search of the literature found no previous reports of such inclusions being seen in biopsied human cowpox lesions. Histopathologists should be aware that such a histological appearance in an unusual vesicular, pustular, or ulcerated skin lesion obtained from a patient with a history of contact with domestic cats probably results from cowpox infection. Figure 1 Histological examination of a punch biopsy of the skin ulcer stained with haematoxylin and eosin (medium power). Numerous, large, eosinophilic type A intracytoplasmic inclusions are seen (arrows). 
Omental actinomycosis presenting with right lower quadrant abdominal pain
A previously healthy 21 year old man presented with a two day history of worsening right lower quadrant abdominal pain. On examination he was found to have a fever (39˚C) and his pulse rate was 110 beats/ minute. There was tenderness with muscle guarding in the right lower quadrant, which worsened after a period of observation. Basic haematology and biochemistry tests were normal. Plain x rays of the chest and abdomen were also normal. A diagnosis of acute appendicitis was made and the patient was transferred for emergency appendicectomy. The appendix proved to be macroscopically normal but a hard and fairly mobile mass was discovered in the right upper quadrant. We decided to extend the original Lantz incision transversely to improve access. The mass was arising from the right side of the greater omentum. It was loosely adherent to the proximal third of the transverse colon and the overlying peritoneum. The other viscera were normal. The mass was freed and excised with a 1 cm margin of macroscopically unaffected omentum. It was round in shape, 7 cm in diameter, and light brown in colour with an uneven surface.
Histological examination using haematoxylin and eosin staining confirmed that the specimen was a non-caseating granulomatous mass featuring eosinophilic granules. A Gram stained smear prepared from the lesion revealed sulfur granules characteristic of actinomycosis, made up of colonies of Gram positive actinomycetes. Therefore, the mass was an omental actinomycoma.
The patient made an uneventful postoperative recovery. We treated him with intravenous crystalline penicillin, 4MU six hourly for two weeks. Before discharge we investigated the patient's gastrointestinal tract with a barium meal with follow through examination to rule out the possibility of an underlying predisposing condition, such as inflammatory bowel disease or an intraluminal lesion. He was discharged on oral amoxicillin, 500 mg eight hourly for a total of four months. We reviewed him six and then 12 months after surgery. On both occasions his white blood cell count, erythrocyte sedimentation rate, C reactive protein, and computed tomography scan of the abdomen and pelvis were completely normal.
Abdominal actinomycosis is an unusual condition, which tends to be a disease of insidious onset and vague symptoms. 1 Recognised causal associations include a history of appendicitis, 2 diverticulitis, 3 inflammatory bowel disease, intrauterine contraceptive device use, 4 or open and endoscopic surgery. However, we found no such association in our patient. Preoperative diagnosis is difficult and requires a high index of suspicion. When actinomycosis is suspected, computed tomography guided aspiration, with or without core biopsy of suspicious lesions, is a useful investigation. 5 This may reduce the number of patients undergoing radical surgery for this benign disease. The role of surgery should be limited to cautious resection of the lesions with delivery of suitable specimens for histology and microbiology.
The organisms tend to be sensitive to cephalosporins, tetracyclines, and macrolides. The duration of treatment is a controversial issue, but long courses are recommended. 1 The prognosis for patients suffering from abdominal actinomycosis is good provided that adequate antibiotic cover is instituted at an early stage.
Incidental freezing artefacts in sentinel lymph node biopsies masquerading as lymphangiography artefacts Sentinel lymph node (SLN) biopsy is a widely used staging procedure. As recently reviewed, possible problems with microscopic interpretation include false positive immunohistochemical staining and benign lesions mimicking metastasis. 1 To my knowledge, no histological artefacts, especially no lymphangiography artefacts, have been attributed to this procedure. I recently encountered an artefact that at first glance seemed to be a lymphangiography artefact.
SLN biopsy is used in our hospital for the staging of breast cancer and was introduced in July 2001. The details of our procedure are as follows. The radioactive tracer is injected intracutaneously or subcutaneously in the affected quadrant of the breast 24 hours before surgery. On the morning of the operation, patent blue dye is injected intracutaneously or subcutaneously in the affected quadrant of the breast. SLN biopsies are fixed in formalin and stored in the operating theatre for 24 hours, after which time, the amount of radioactivity is low enough for the specimens to be transported by public highway with no special measures or a licence.
In March 2003, we received two SLN biopsies on the same day, both with artefacts. Throughout the lymph nodes there were empty holes with no reactive changes (fig 1) . A similar artefact was noted in the tumour of one of the lumpectomy specimens, making grading of this tumour impossible. All tissues seemed to be adequately fixed in formalin and paraffin wax embedded. No artefacts were noted in other specimens that were processed on the same day. A link was made with the SLN procedure and the artefacts were interpreted as possible lymphangiography artefacts. The departments of surgery and nuclear medicine were contacted to ask whether there had been any changes in the SLN procedure. Both of these departments denied changes to their procedures; specifically, neither of the two tracers was injected in or near the tumour and there was no change in the composition of the tracers. The SLNs taken in 2002 were reviewed and it was noted that the first SLN with the same artefact was taken in the last week of December and the same artefact was also seen in SLNs from January and February 2003. However, the lymph nodes were assessed by different pathologists and the artefacts were not interpreted as related to the SLN procedure.
The department of surgery was again contacted and one of the nurses from the operating theatre mentioned that the SLN biopsies were stored in a refrigerator until transportation. This refrigerator had been switched on after reorganisation of the operating theatre in December 2002, but before that date it had been switched off. On several occasions she had noticed that tissues stored in the refrigerator were frozen and for this reason the refrigerator had been serviced twice, although no improvement was seen. This problem had not been reported to our laboratory and we had never noticed that the SLN specimens were frozen on arrival. We concluded that the artefacts in the SLNs were freezing artefacts and the refrigerator was switched off. Since then the artefact has disappeared.
P J Westenend
Pathologisch Laboratorium voor Dordrecht eo, Laan van Londen 1800, Dordrecht, 3317 DA, The Netherlands; pwestenend@paldordt.com The style of the book is very simple and the reader is ''talked'' through the dissection. There are line drawings of the specimens and where sections of the specimen should be taken from. Although in black and white, this does not detract from the essence of the book. As such, it is an excellent instruction manual that should form the basis of every cut up manual anywhere in the world. Although there are regional variations and personal quirks, there is only one way to gross a specimen properly and that is the right way. This book will point anyone who is at the cut up bench in the right direction.
I thoroughly recommend this book to all registrars, pathologists, and pathologist's assistants.
R Chetty
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Practical Pulmonary Pathology
Because I am particularly obsessed with standardisation of the grossing of specimens, reviewing a book devoted entirely to this extremely important aspect of surgical pathology was something I did with relish.
As is set out in the foreword, the grossing guidelines contained in the book conform, in In addition, this author would like it to be known that she did not see the proofs before the paper was published.
